Global Immuno-oncology Clinical Trials Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Page: 93

Published Date: 30 Jun 2021

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Immuno-oncology Clinical Trials market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Immuno-oncology Clinical Trials size is estimated to be USD XX million in 2026 from USD XX million in 2020, with a change XX% between 2020 and 2021. The global Immuno-oncology Clinical Trials market size is expected to grow at a CAGR of XX% for the next five years.

Market segmentation
Immuno-oncology Clinical Trials market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Phase I
    Phase II
    Phase III
    Phase IV

Market segment by Application, can be divided into
    Solid Tumors
    Hematological Cancer

Market segment by players, this report covers
    Medpace
    Novartis
    Exscientia
    Syneous Health
    AstraZeneca
    ICON plc
    IQVIA Holdings
    BioNtech
    Covance, Inc.
    IO BIOTECH

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Immuno-oncology Clinical Trials product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Immuno-oncology Clinical Trials, with revenue, gross margin and global market share of Immuno-oncology Clinical Trials from 2019 to 2021.
Chapter 3, the Immuno-oncology Clinical Trials competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Immuno-oncology Clinical Trials market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Immuno-oncology Clinical Trials research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Immuno-oncology Clinical Trials
    1.2 Classification of Immuno-oncology Clinical Trials by Type
        1.2.1 Overview: Global Immuno-oncology Clinical Trials Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global Immuno-oncology Clinical Trials Revenue Market Share by Type in 2020
        1.2.3 Phase I
        1.2.4 Phase II
        1.2.5 Phase III
        1.2.6 Phase IV
    1.3 Global Immuno-oncology Clinical Trials Market by Application
        1.3.1 Overview: Global Immuno-oncology Clinical Trials Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Solid Tumors
        1.3.3 Hematological Cancer
    1.4 Global Immuno-oncology Clinical Trials Market Size & Forecast
    1.5 Global Immuno-oncology Clinical Trials Market Size and Forecast by Region
        1.5.1 Global Immuno-oncology Clinical Trials Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global Immuno-oncology Clinical Trials Market Size by Region, (2016-2021)
        1.5.3 North America Immuno-oncology Clinical Trials Market Size and Prospect (2016-2026)
        1.5.4 Europe Immuno-oncology Clinical Trials Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific Immuno-oncology Clinical Trials Market Size and Prospect (2016-2026)
        1.5.6 South America Immuno-oncology Clinical Trials Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa Immuno-oncology Clinical Trials Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Immuno-oncology Clinical Trials Market Drivers
        1.6.2 Immuno-oncology Clinical Trials Market Restraints
        1.6.3 Immuno-oncology Clinical Trials Trends Analysis

2 Company Profiles
    2.1 Medpace
        2.1.1 Medpace Details
        2.1.2 Medpace Major Business
        2.1.3 Medpace Immuno-oncology Clinical Trials Product and Solutions
        2.1.4 Medpace Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 Medpace Recent Developments and Future Plans
    2.2 Novartis
        2.2.1 Novartis Details
        2.2.2 Novartis Major Business
        2.2.3 Novartis Immuno-oncology Clinical Trials Product and Solutions
        2.2.4 Novartis Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 Novartis Recent Developments and Future Plans
    2.3 Exscientia
        2.3.1 Exscientia Details
        2.3.2 Exscientia Major Business
        2.3.3 Exscientia Immuno-oncology Clinical Trials Product and Solutions
        2.3.4 Exscientia Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 Exscientia Recent Developments and Future Plans
    2.4 Syneous Health
        2.4.1 Syneous Health Details
        2.4.2 Syneous Health Major Business
        2.4.3 Syneous Health Immuno-oncology Clinical Trials Product and Solutions
        2.4.4 Syneous Health Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 Syneous Health Recent Developments and Future Plans
    2.5 AstraZeneca
        2.5.1 AstraZeneca Details
        2.5.2 AstraZeneca Major Business
        2.5.3 AstraZeneca Immuno-oncology Clinical Trials Product and Solutions
        2.5.4 AstraZeneca Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 AstraZeneca Recent Developments and Future Plans
    2.6 ICON plc
        2.6.1 ICON plc Details
        2.6.2 ICON plc Major Business
        2.6.3 ICON plc Immuno-oncology Clinical Trials Product and Solutions
        2.6.4 ICON plc Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 ICON plc Recent Developments and Future Plans
    2.7 IQVIA Holdings
        2.7.1 IQVIA Holdings Details
        2.7.2 IQVIA Holdings Major Business
        2.7.3 IQVIA Holdings Immuno-oncology Clinical Trials Product and Solutions
        2.7.4 IQVIA Holdings Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 IQVIA Holdings Recent Developments and Future Plans
    2.8 BioNtech
        2.8.1 BioNtech Details
        2.8.2 BioNtech Major Business
        2.8.3 BioNtech Immuno-oncology Clinical Trials Product and Solutions
        2.8.4 BioNtech Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 BioNtech Recent Developments and Future Plans
    2.9 Covance, Inc.
        2.9.1 Covance, Inc. Details
        2.9.2 Covance, Inc. Major Business
        2.9.3 Covance, Inc. Immuno-oncology Clinical Trials Product and Solutions
        2.9.4 Covance, Inc. Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 Covance, Inc. Recent Developments and Future Plans
    2.10 IO BIOTECH
        2.10.1 IO BIOTECH Details
        2.10.2 IO BIOTECH Major Business
        2.10.3 IO BIOTECH Immuno-oncology Clinical Trials Product and Solutions
        2.10.4 IO BIOTECH Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2021)
        2.10.5 IO BIOTECH Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Immuno-oncology Clinical Trials Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Immuno-oncology Clinical Trials Players Market Share
        3.2.2 Top 10 Immuno-oncology Clinical Trials Players Market Share
        3.2.3 Market Competition Trend
    3.3 Immuno-oncology Clinical Trials Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type
    4.1 Global Immuno-oncology Clinical Trials Revenue and Market Share by Type (2016-2021)
    4.2 Global Immuno-oncology Clinical Trials Market Forecast by Type (2021-2026)

5 Market Size Segment by Application
    5.1 Global Immuno-oncology Clinical Trials Revenue Market Share by Application (2016-2021)
    5.2 Immuno-oncology Clinical Trials Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application
    6.1 North America Immuno-oncology Clinical Trials Revenue by Type (2016-2026)
    6.2 North America Immuno-oncology Clinical Trials Revenue by Application (2016-2026)
    6.3 North America Immuno-oncology Clinical Trials Market Size by Country
        6.3.1 North America Immuno-oncology Clinical Trials Revenue by Country (2016-2026)
        6.3.2 United States Immuno-oncology Clinical Trials Market Size and Forecast (2016-2026)
        6.3.3 Canada Immuno-oncology Clinical Trials Market Size and Forecast (2016-2026)
        6.3.4 Mexico Immuno-oncology Clinical Trials Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application
    7.1 Europe Immuno-oncology Clinical Trials Revenue by Type (2016-2026)
    7.2 Europe Immuno-oncology Clinical Trials Revenue by Application (2016-2026)
    7.3 Europe Immuno-oncology Clinical Trials Market Size by Country
        7.3.1 Europe Immuno-oncology Clinical Trials Revenue by Country (2016-2026)
        7.3.2 Germany Immuno-oncology Clinical Trials Market Size and Forecast (2016-2026)
        7.3.3 France Immuno-oncology Clinical Trials Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom Immuno-oncology Clinical Trials Market Size and Forecast (2016-2026)
        7.3.5 Russia Immuno-oncology Clinical Trials Market Size and Forecast (2016-2026)
        7.3.6 Italy Immuno-oncology Clinical Trials Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Immuno-oncology Clinical Trials Revenue by Type (2016-2026)
    8.2 Asia-Pacific Immuno-oncology Clinical Trials Revenue by Application (2016-2026)
    8.3 Asia-Pacific Immuno-oncology Clinical Trials Market Size by Region
        8.3.1 Asia-Pacific Immuno-oncology Clinical Trials Revenue by Region (2016-2026)
        8.3.2 China Immuno-oncology Clinical Trials Market Size and Forecast (2016-2026)
        8.3.3 Japan Immuno-oncology Clinical Trials Market Size and Forecast (2016-2026)
        8.3.4 South Korea Immuno-oncology Clinical Trials Market Size and Forecast (2016-2026)
        8.3.5 India Immuno-oncology Clinical Trials Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia Immuno-oncology Clinical Trials Market Size and Forecast (2016-2026)
        8.3.7 Australia Immuno-oncology Clinical Trials Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application
    9.1 South America Immuno-oncology Clinical Trials Revenue by Type (2016-2026)
    9.2 South America Immuno-oncology Clinical Trials Revenue by Application (2016-2026)
    9.3 South America Immuno-oncology Clinical Trials Market Size by Country
        9.3.1 South America Immuno-oncology Clinical Trials Revenue by Country (2016-2026)
        9.3.2 Brazil Immuno-oncology Clinical Trials Market Size and Forecast (2016-2026)
        9.3.3 Argentina Immuno-oncology Clinical Trials Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Immuno-oncology Clinical Trials Revenue by Type (2016-2026)
    10.2 Middle East & Africa Immuno-oncology Clinical Trials Revenue by Application (2016-2026)
    10.3 Middle East & Africa Immuno-oncology Clinical Trials Market Size by Country
        10.3.1 Middle East & Africa Immuno-oncology Clinical Trials Revenue by Country (2016-2026)
        10.3.2 Turkey Immuno-oncology Clinical Trials Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia Immuno-oncology Clinical Trials Market Size and Forecast (2016-2026)
        10.3.4 UAE Immuno-oncology Clinical Trials Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Immuno-oncology Clinical Trials Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
    Table 2. Global Immuno-oncology Clinical Trials Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
    Table 3. Global Market Immuno-oncology Clinical Trials Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
    Table 4. Global Immuno-oncology Clinical Trials Revenue (USD Million) by Region (2016-2021)
    Table 5. Global Immuno-oncology Clinical Trials Revenue Market Share by Region (2021-2026)
    Table 6. Medpace Corporate Information, Head Office, and Major Competitors
    Table 7. Medpace Major Business
    Table 8. Medpace Immuno-oncology Clinical Trials Product and Solutions
    Table 9. Medpace Immuno-oncology Clinical Trials Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 10. Novartis Corporate Information, Head Office, and Major Competitors
    Table 11. Novartis Major Business
    Table 12. Novartis Immuno-oncology Clinical Trials Product and Solutions
    Table 13. Novartis Immuno-oncology Clinical Trials Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 14. Exscientia Corporate Information, Head Office, and Major Competitors
    Table 15. Exscientia Major Business
    Table 16. Exscientia Immuno-oncology Clinical Trials Product and Solutions
    Table 17. Exscientia Immuno-oncology Clinical Trials Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 18. Syneous Health Corporate Information, Head Office, and Major Competitors
    Table 19. Syneous Health Major Business
    Table 20. Syneous Health Immuno-oncology Clinical Trials Product and Solutions
    Table 21. Syneous Health Immuno-oncology Clinical Trials Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 22. AstraZeneca Corporate Information, Head Office, and Major Competitors
    Table 23. AstraZeneca Major Business
    Table 24. AstraZeneca Immuno-oncology Clinical Trials Product and Solutions
    Table 25. AstraZeneca Immuno-oncology Clinical Trials Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 26. ICON plc Corporate Information, Head Office, and Major Competitors
    Table 27. ICON plc Major Business
    Table 28. ICON plc Immuno-oncology Clinical Trials Product and Solutions
    Table 29. ICON plc Immuno-oncology Clinical Trials Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 30. IQVIA Holdings Corporate Information, Head Office, and Major Competitors
    Table 31. IQVIA Holdings Major Business
    Table 32. IQVIA Holdings Immuno-oncology Clinical Trials Product and Solutions
    Table 33. IQVIA Holdings Immuno-oncology Clinical Trials Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 34. BioNtech Corporate Information, Head Office, and Major Competitors
    Table 35. BioNtech Major Business
    Table 36. BioNtech Immuno-oncology Clinical Trials Product and Solutions
    Table 37. BioNtech Immuno-oncology Clinical Trials Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 38. Covance, Inc. Corporate Information, Head Office, and Major Competitors
    Table 39. Covance, Inc. Major Business
    Table 40. Covance, Inc. Immuno-oncology Clinical Trials Product and Solutions
    Table 41. Covance, Inc. Immuno-oncology Clinical Trials Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 42. IO BIOTECH Corporate Information, Head Office, and Major Competitors
    Table 43. IO BIOTECH Major Business
    Table 44. IO BIOTECH Immuno-oncology Clinical Trials Product and Solutions
    Table 45. IO BIOTECH Immuno-oncology Clinical Trials Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 46. Global Immuno-oncology Clinical Trials Revenue (USD Million) by Players (2019-2021)
    Table 47. Global Immuno-oncology Clinical Trials Revenue Share by Players (2019-2021)
    Table 48. Breakdown of Immuno-oncology Clinical Trials by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 49. Immuno-oncology Clinical Trials Players Head Office, Products and Services Provided
    Table 50. Immuno-oncology Clinical Trials Mergers & Acquisitions in the Past Five Years
    Table 51. Immuno-oncology Clinical Trials New Entrants and Expansion Plans
    Table 52. Global Immuno-oncology Clinical Trials Revenue (USD Million) by Type (2016-2021)
    Table 53. Global Immuno-oncology Clinical Trials Revenue Share by Type (2016-2021)
    Table 54. Global Immuno-oncology Clinical Trials Revenue Forecast by Type (2021-2026)
    Table 55. Global Immuno-oncology Clinical Trials Revenue by Application (2016-2021)
    Table 56. Global Immuno-oncology Clinical Trials Revenue Forecast by Application (2021-2026)
    Table 57. North America Immuno-oncology Clinical Trials Revenue by Type (2016-2021) & (USD Million)
    Table 58. North America Immuno-oncology Clinical Trials Revenue by Type (2021-2026) & (USD Million)
    Table 59. North America Immuno-oncology Clinical Trials Revenue by Application (2016-2021) & (USD Million)
    Table 60. North America Immuno-oncology Clinical Trials Revenue by Application (2021-2026) & (USD Million)
    Table 61. North America Immuno-oncology Clinical Trials Revenue by Country (2016-2021) & (USD Million)
    Table 62. North America Immuno-oncology Clinical Trials Revenue by Country (2021-2026) & (USD Million)
    Table 63. Europe Immuno-oncology Clinical Trials Revenue by Type (2016-2021) & (USD Million)
    Table 64. Europe Immuno-oncology Clinical Trials Revenue by Type (2021-2026) & (USD Million)
    Table 65. Europe Immuno-oncology Clinical Trials Revenue by Application (2016-2021) & (USD Million)
    Table 66. Europe Immuno-oncology Clinical Trials Revenue by Application (2021-2026) & (USD Million)
    Table 67. Europe Immuno-oncology Clinical Trials Revenue by Country (2016-2021) & (USD Million)
    Table 68. Europe Immuno-oncology Clinical Trials Revenue by Country (2021-2026) & (USD Million)
    Table 69. Asia-Pacific Immuno-oncology Clinical Trials Revenue by Type (2016-2021) & (USD Million)
    Table 70. Asia-Pacific Immuno-oncology Clinical Trials Revenue by Type (2021-2026) & (USD Million)
    Table 71. Asia-Pacific Immuno-oncology Clinical Trials Revenue by Application (2016-2021) & (USD Million)
    Table 72. Asia-Pacific Immuno-oncology Clinical Trials Revenue by Application (2021-2026) & (USD Million)
    Table 73. Asia-Pacific Immuno-oncology Clinical Trials Revenue by Region (2016-2021) & (USD Million)
    Table 74. Asia-Pacific Immuno-oncology Clinical Trials Revenue by Region (2021-2026) & (USD Million)
    Table 75. South America Immuno-oncology Clinical Trials Revenue by Type (2016-2021) & (USD Million)
    Table 76. South America Immuno-oncology Clinical Trials Revenue by Type (2021-2026) & (USD Million)
    Table 77. South America Immuno-oncology Clinical Trials Revenue by Application (2016-2021) & (USD Million)
    Table 78. South America Immuno-oncology Clinical Trials Revenue by Application (2021-2026) & (USD Million)
    Table 79. South America Immuno-oncology Clinical Trials Revenue by Country (2016-2021) & (USD Million)
    Table 80. South America Immuno-oncology Clinical Trials Revenue by Country (2021-2026) & (USD Million)
    Table 81. Middle East & Africa Immuno-oncology Clinical Trials Revenue by Type (2016-2021) & (USD Million)
    Table 82. Middle East & Africa Immuno-oncology Clinical Trials Revenue by Type (2021-2026) & (USD Million)
    Table 83. Middle East & Africa Immuno-oncology Clinical Trials Revenue by Application (2016-2021) & (USD Million)
    Table 84. Middle East & Africa Immuno-oncology Clinical Trials Revenue by Application (2021-2026) & (USD Million)
    Table 85. Middle East & Africa Immuno-oncology Clinical Trials Revenue by Country (2016-2021) & (USD Million)
    Table 86. Middle East & Africa Immuno-oncology Clinical Trials Revenue by Country (2021-2026) & (USD Million)
List of Figures
    Figure 1. Immuno-oncology Clinical Trials Picture
    Figure 2. Global Immuno-oncology Clinical Trials Revenue Market Share by Type in 2020
    Figure 3. Phase I
    Figure 4. Phase II
    Figure 5. Phase III
    Figure 6. Phase IV
    Figure 7. Immuno-oncology Clinical Trials Revenue Market Share by Application in 2020
    Figure 8. Solid Tumors Picture
    Figure 9. Hematological Cancer Picture
    Figure 10. Global Immuno-oncology Clinical Trials Revenue, (USD Million): 2020 VS 2021 VS 2026
    Figure 11. Global Immuno-oncology Clinical Trials Revenue and Forecast (2016-2026) & (USD Million)
    Figure 12. Global Immuno-oncology Clinical Trials Revenue Market Share by Region (2016-2026)
    Figure 13. Global Immuno-oncology Clinical Trials Revenue Market Share by Region in 2020
    Figure 14. North America Immuno-oncology Clinical Trials Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 15. Europe Immuno-oncology Clinical Trials Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 16. Asia-Pacific Immuno-oncology Clinical Trials Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 17. South America Immuno-oncology Clinical Trials Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 18. Middle East and Africa Immuno-oncology Clinical Trials Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 19. Immuno-oncology Clinical Trials Market Drivers
    Figure 20. Immuno-oncology Clinical Trials Market Restraints
    Figure 21. Immuno-oncology Clinical Trials Market Trends
    Figure 22. Medpace Recent Developments and Future Plans
    Figure 23. Novartis Recent Developments and Future Plans
    Figure 24. Exscientia Recent Developments and Future Plans
    Figure 25. Syneous Health Recent Developments and Future Plans
    Figure 26. AstraZeneca Recent Developments and Future Plans
    Figure 27. ICON plc Recent Developments and Future Plans
    Figure 28. IQVIA Holdings Recent Developments and Future Plans
    Figure 29. BioNtech Recent Developments and Future Plans
    Figure 30. Covance, Inc. Recent Developments and Future Plans
    Figure 31. IO BIOTECH Recent Developments and Future Plans
    Figure 32. Global Immuno-oncology Clinical Trials Revenue Share by Players in 2020
    Figure 33. Immuno-oncology Clinical Trials Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    Figure 34. Global Top 3 Players Immuno-oncology Clinical Trials Revenue Market Share in 2020
    Figure 35. Global Top 10 Players Immuno-oncology Clinical Trials Revenue Market Share in 2020
    Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
    Figure 37. Global Immuno-oncology Clinical Trials Revenue Share by Type in 2020
    Figure 38. Global Immuno-oncology Clinical Trials Market Share Forecast by Type (2021-2026)
    Figure 39. Global Immuno-oncology Clinical Trials Revenue Share by Application in 2020
    Figure 40. Global Immuno-oncology Clinical Trials Market Share Forecast by Application (2021-2026)
    Figure 41. North America Immuno-oncology Clinical Trials Sales Market Share by Type (2016-2026)
    Figure 42. North America Immuno-oncology Clinical Trials Sales Market Share by Application (2016-2026)
    Figure 43. North America Immuno-oncology Clinical Trials Revenue Market Share by Country (2016-2026)
    Figure 44. United States Immuno-oncology Clinical Trials Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 45. Canada Immuno-oncology Clinical Trials Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 46. Mexico Immuno-oncology Clinical Trials Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 47. Europe Immuno-oncology Clinical Trials Sales Market Share by Type (2016-2026)
    Figure 48. Europe Immuno-oncology Clinical Trials Sales Market Share by Application (2016-2026)
    Figure 49. Europe Immuno-oncology Clinical Trials Revenue Market Share by Country (2016-2026)
    Figure 50. Germany Immuno-oncology Clinical Trials Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 51. France Immuno-oncology Clinical Trials Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 52. United Kingdom Immuno-oncology Clinical Trials Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 53. Russia Immuno-oncology Clinical Trials Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 54. Italy Immuno-oncology Clinical Trials Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 55. Asia-Pacific Immuno-oncology Clinical Trials Sales Market Share by Type (2016-2026)
    Figure 56. Asia-Pacific Immuno-oncology Clinical Trials Sales Market Share by Application (2016-2026)
    Figure 57. Asia-Pacific Immuno-oncology Clinical Trials Revenue Market Share by Region (2016-2026)
    Figure 58. China Immuno-oncology Clinical Trials Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 59. Japan Immuno-oncology Clinical Trials Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 60. South Korea Immuno-oncology Clinical Trials Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 61. India Immuno-oncology Clinical Trials Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 62. Southeast Asia Immuno-oncology Clinical Trials Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 63. Australia Immuno-oncology Clinical Trials Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 64. South America Immuno-oncology Clinical Trials Sales Market Share by Type (2016-2026)
    Figure 65. South America Immuno-oncology Clinical Trials Sales Market Share by Application (2016-2026)
    Figure 66. South America Immuno-oncology Clinical Trials Revenue Market Share by Country (2016-2026)
    Figure 67. Brazil Immuno-oncology Clinical Trials Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 68. Argentina Immuno-oncology Clinical Trials Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 69. Middle East and Africa Immuno-oncology Clinical Trials Sales Market Share by Type (2016-2026)
    Figure 70. Middle East and Africa Immuno-oncology Clinical Trials Sales Market Share by Application (2016-2026)
    Figure 71. Middle East and Africa Immuno-oncology Clinical Trials Revenue Market Share by Country (2016-2026)
    Figure 72. Turkey Immuno-oncology Clinical Trials Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 73. Saudi Arabia Immuno-oncology Clinical Trials Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 74. UAE Immuno-oncology Clinical Trials Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 75. Methodology
    Figure 76. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Medpace
Novartis
Exscientia
Syneous Health
AstraZeneca
ICON plc
IQVIA Holdings
BioNtech
Covance, Inc.
IO BIOTECH

Related Reports

Global Immuno-oncology Clinical Trials Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Global Immuno-oncology Clinical Trials Market 2022 by Company, Regions, Type and Application, Forecast to 2028

date 14 Jan 2022

date Medical Care

The Immuno-oncology Clinical Trials market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Product Tags

immuno oncology clinical trials

Immuno-oncology Clinical Trials

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>